ReviewFrontiers in immunology2026
PYHIN proteins: guardians or contributors to hepatitis B virus pathogenesis?
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human pyrin and HIN domain (PYHIN) family proteins play central roles in the host defense against viral infection. These PYHIN proteins, including IFI16, AIM2, MNDA and PYHIN1, mainly function as intracellular DNA sensors. Among them, IFI16 is supported by the most robust mechanistic evidence, including direct binding to hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the nucleus and subsequent suppression of viral transcription. They recognize HBV DNA in different cellular substructures, triggering innate immune responses and interfering with steps of the viral life cycle. This article reviews the latest research progress of the PYHIN protein in HBV infection, and summarizes its immunoregulatory function and its role in the disease progression. We focus on the important question of the dual antiviral and pro-damage functions of PYHIN. On one hand, PYHIN has the ability to sense HBV DNA and inhibit the replication of the HBV. On the other hand, the host response mediated by PYHIN may also promote chronic inflammation, genomic instability and tumor formation. Furthermore, we collated the mechanism by which HBV evaded inflammasome activation by suppressing PYHIN expression through HBx. Here, we have emphasized the necessity of conducting in-depth mechanism research to clarify the role of the PYHIN family proteins in HBV infection contexts, and proposed the feasibility of implementing precise targeted immunotherapy based on the functions of PYHIN, aiming to provide strategies for achieving hepatitis B cure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.